Johnson, Bankole A.
University of Maryland, Baltimore
9 papers on CoChatORCID 0000-0002-8901-6177
Most cited papers
- Verified
Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence: The COMBINE Study: A Randomized Controlled Trial
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA
Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects
Cited by 1,930
- Verified
Oral topiramate for treatment of alcohol dependence: A randomised controlled trial
Johnson, B. A., Ait-Daoud, N., Bowden, C. L., DiClemente, C. C., Roache, J. D., Lawson, K., Javors, M. A., & Ma, J. Z. (2003) · The Lancet
Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects
Cited by 743
- Verified · note
Topiramate for Treating Alcohol Dependence<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
Johnson, B. A. (2007) · JAMA
Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects
Cited by 542
- Verified
A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence
Litten, R. Z., Ryan, M. L., Fertig, J. B., Falk, D. E., Johnson, B., Dunn, K. E., Green, A. I., Pettinati, H. M., Ciraulo, D. A., Sarid-Segal, O., et al. (2013) · Journal of Addiction Medicine
Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects
Cited by 287
- Verified
Medication treatment of different types of alcoholism
Johnson, B. A. (2010) · American Journal of Psychiatry
Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior
Cited by 151
- Verified
Topiramate for the Treatment of Cocaine Addiction: A Randomized Clinical Trial
Johnson, B. A., Ait-Daoud, N., Wang, X.-Q., Penberthy, J. K., Javors, M. A., Seneviratne, C., & Liu, L. (2013) · JAMA Psychiatry
Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior
Cited by 133
- Verified
Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials
Falk, D. E., O’Malley, S. S., Witkiewitz, K., Anton, R. F., Litten, R. Z., Slater, M., Kranzler, H. R., Mann, K. F., Hasin, D. S., Johnson, B., et al. (2019) · JAMA Psychiatry
Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects
Cited by 120
- Verified
A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence
for the National Institute on Alcohol Abuse and Alcoholism Clinical Investigations Group (NCIG) Study Group, Ryan, M. L., Falk, D. E., Fertig, J. B., Rendenbach-Mueller, B., Katz, D. A., Tracy, K. A., Strain, E. C., Dunn, K. E., Kampman, K., et al. (2017) · Neuropsychopharmacology
Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects
Cited by 72
- Verified
Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition
Johnson, B. A., Roache, J. D., Ait-Daoud, N., Wallace, C., Wells, L. T., & Wang, Y. (2005) · Psychopharmacology
Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes
Cited by 33
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free